Latest News
Eanm has launched a new award to accelerate alpha radioligand therapy research in prostate cancer, with winners to be announced at the EANM’26 Congress. Applications are now open for the 2026 EANM Young Scientist Network Award. The research award is supported by Advanced Accelerator Applications, a Novartis company, and focuses on advancing alpha radioligand therapy [...]
Apple Watch hypertension alerts may miss cases of high blood pressure, with the absence of an alert offering limited reassurance, particularly for older adults, researchers say. Hypertension, or high blood pressure, occurs when blood consistently pushes too forcefully against artery walls, increasing the risk of heart disease and stroke. The study applied performance data from [...]
Eye care startup Custom Surgical has raised €3.5m to modernise ophthalmology by turning analogue slit lamps and microscopes into digital data hubs. Munich-based Custom Surgical was founded in 2018 by mechatronics engineer Federico Acosta and Fernando Benito. It specialises in digitalising slit lamps and surgical microscopes used in everyday eye care. Slit lamps are standard [...]
PrimeC showed a more than 14-month survival benefit in an ALS trial, according to updated long-term data from NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd announced updated long-term survival data from its completed Phase 2b PARADIGM clinical trial of its investigational therapy PrimeC in patients with amyotrophic lateral sclerosis (ALS), according to the company. The analysis [...]
Researchers are studying recovery after bowel cancer treatment in older people, as the REBOUND study looks at ageing changes linked to surgery and care. The study, Resilience Breakthroughs in Older people Undergoing cancer proceDures, is examining how key "hallmarks of ageing" are affected following bowel cancer treatment in people aged 65 and over. These are [...]
Korsana Biosciences has emerged from stealth with US$175m to develop an Alzheimer’s antibody designed to boost amyloid plaque clearance. The Waltham, Massachusetts-based biotech is focused on neurodegenerative disease. Its lead programme, KRSA-028, is a next-generation shuttled monoclonal antibody targeting amyloid beta, a protein that can build up into plaques in Alzheimer’s. The treatment uses the [...]
Regenerative innovator's cash boost, are biological clocks out of time?, Y chromosome concerns, £60bn of graft by UK pensioners Indian regenerative medicine company Pandorum Technologies, has raised US$18m in a Series B funding round to support its clinical developments and global expansion. The company, which operates the United States as well as its domestic market, [...]
GSK has signed a five-year deal with JAX-NYSCF to build stem cell models for neurodegenerative disease, with Alzheimer’s a key target. The collaboration with The Jackson Laboratory-New York Stem Cell Foundation Collaborative aims to combine human stem cell research with large-scale research systems to help bridge discovery and drug development. The partners plan to develop [...]
Long-term air pollution exposure may raise Alzheimer’s risk mainly through direct effects on the brain, a study of US Medicare records suggests. The research followed more than 27.8m US Medicare recipients aged 65 and over from 2000 to 2018, comparing estimated pollution exposure with later Alzheimer’s diagnoses. Researchers focused on PM2.5, very fine particles smaller [...]
An AI model using gait data before and after hip replacement could help predict which patients will walk close to normal and who may need extra rehabilitation. The tool analyses gait biomechanics, the study of how people walk, using data collected before and after operations in people with hip osteoarthritis, caused by cartilage wear in [...]
